Gilead Sciences, Inc. announced this week that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the...
NewsDesk @bactiman63
Genentech today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult...
NewsDesk @bactiman63
Tarsus Pharmaceuticals, Inc. announced positive topline results from the completed Phase 1b Callisto trial and the enrollment of the first subject in the Carpo Phase 2a trial. The...
NewsDesk @bactiman63
A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published in eLife.
The study suggests that...
NewsDesk @bactiman63
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new...
NewsDesk @bactiman63
A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists at the University of Bath led by Dr Maisem Laabei and Dr...
NewsDesk @bactiman63
A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators...
NewsDesk @bactiman63
Researchers at Karolinska Institutet in Sweden have identified key signalling pathways that when blocked by existing drug candidates limit reproduction of the Crimean-Congo hemorrhagic...
NewsDesk @bactiman63
Ivermectin is a drug approved by the United States Food and Drug Administration (FDA) to treat parasites in animals and in humans with intestinal strongyloidiasis (roundworm) and onchocerciasis (river...
Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions:...
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.